Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer chez ACOTEC SCIENTIFIC HOLDINGS LIMITED
Postes actifs de Ulrich Reinhold Speck
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 29/01/2021 | - |
Historique de carrière de Ulrich Reinhold Speck
Anciens postes connus de Ulrich Reinhold Speck
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
InnoRa GmbH
 InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 01/01/2001 | 18/01/2017 |
| General Counsel | 14/01/2002 | 18/01/2017 | |
| Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 01/01/2000 | 01/01/2001 |
Formation de Ulrich Reinhold Speck
| Freie Universität Berlin | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Chine | 2 |
Opérationnelle
| Founder | 1 |
| General Counsel | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |
- Bourse
- Insiders
- Ulrich Reinhold Speck
- Expérience
